Skip to main content
. 2014 Feb 11;9(2):e88698. doi: 10.1371/journal.pone.0088698

Table 1. WE-14 plasma concentrations in healthy volunteers and patients with pheochromocytoma.

WE-14 (ng/ml) Sensitivity (%)
Median Minimal value Maximal value WE-14 CgA EM66 WE-14 +CgA WE-14 +EM66 CgA +EM66 WE-14 +CgA+EM66
Controls (n = 21) 0.689 0.525 2.106 - - - - - - -
Patients (n = 37) 3.695*** 0.494 61.027 83.8 83.8 83.8 91.9 91.9 89,2 94,6
Postoperative (n = 12) 1.154 0.382 1.997 - - - - - - -
Pheochromocytoma (n = 26) 3.204*** 0.896 61.027 80,8 84,6 80,8 92,3 88,5 88,5 92,3
Paraganglioma (n = 11) 5.484*** 0.494 47.245 90,9 81,8 90,9 90,9 100 90,9 100
Benign (n = 32) 3.776*** 0.494 47.245 84,4 84,4 90,6 90,6 93,8 90,6 93,8
Malignant (n = 5) 3.078* 1.345 61.027 80 80 40 100 80 80 100
Sporadic (n = 24) 4.224*** 1.303 61.027 91,7 95,8 87,5 100 95,8 95,8 100
Hereditary (n = 13) 2.542* 0.494 19.354 69,2 61,5 76,9 76,9 84,6 76,9 84,6

Comparison of the diagnostic sensitivity of WE-14, CgA and EM66 assays.

*, median value of controls vs median value of patients, pheochromocytoma, paraganglioma, benign, malignant, sporadic or hereditary tumors. * p<0.05, *** p<0.001; n, number of individuals.